Polysaccharides as supports for antiviral and antitumoral drugs

Polysaccharides in Medicinal Applications

Volumn , Issue , 2017, Pages 765-779

  Uglea, Constantin V ^a   Ottenbrite, Raphael M ^b  

^a INSTITUTE OF BIOLOGICAL RESEARCH   (Romania)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITUMORAL DRUGS; EXCHANGE OF INFORMATION; LIVING SYSTEMS; MACROMOLECULAR DRUGS;

EID: 27844556538     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203742815     Document Type: Chapter

References (19)

1. P. Ehrlich, Coll. Stud. Immunol., 2, 42 (1906).
2. R. M. Ottenbrite, Polymers in Biotechnology (M. Phillips, S. P. Shoemaker, R. D. Middlekauf and R. M. Ottenbrite, eds.), ACS Symposium series No. 362, 1986, ACS, Washington D.C., 1988, p. 122.
3. P. Claes, Chlorite oxidized amylase as antitumoral drug, J. Virusol., 5, 313 (1970).
4. R. M. Ottenbrite, W. Regelson, A. Kaplan, R. Carchman, P. Marahan, and A. Munson in Anionic Polymeric Drugs (R. M. Ottenbrite, L. G. Donaruma, and O. Vogl, eds.), Wiley-Interscience, New York, 1980, p. 263.
5. C. V. Uglea, A. Vatajanu, D. Iurea, H. Offenberg, A. Grecianu, and I.I. Negulescu, Anesthesine modified polysaccharides. I. Synthesis and characterization, Polym. Preprints, 33 No. 2, 96 (1992).
6. R. H. Adamson, Search for New Drugs (A. Rubin, ed.), Dekker, New York, 1972, p. 292-311.
7. C. I. Simionescu, S. Dumitriu, V. Bulachovschi, and V. Popa, Bioactive polymers. III. Cellulose derivatives as support for biologically active compounds, J. Polym. Sci. Polym. Symp., 66, 171 (1979).
8. B. M. Markaverich, R. R. Gregory, M. A. Alejandro, G. A. Johnson, and B. S. Middleditch, Methyl p-hydroxyphenylactate: identification in rat liver extracts, J. High Resolut. Chromatogr., Chromatogr Commun., 11, 605 (1988).
9. R. R. Brown, R. Bain, and V. C. Jordan, Determination of tamoxifen in human serum by high performance liquid chromatography with post-column fluorescence activation, J. Chromatogr, 272, 351 (1983).
10. A. B. Edman and I. Kiessling, Study of benzocaine effect upon the isolated frog muscle fiber, Biochem. Biophys. Acta, 442, 629 (1976).
11. M. Isac, The effect of aromatic aminoesters on the isolated frog muscle fiber, Rev. Roumaine Chim., 18, 232(1978).
12. C. L. Voiculescu, C. Nedelcu, F. Micsich, O. Chita, S. Rogoz, and L. Stanciu in Immunomodulation by Microbial Products and Related Synthetic Compounds (Y. Yamamura, S. Kotani, I. Azuma, A. Koda, and T. Shiba, eds.), Excerpta Medica, Amsterdam, 1982, p. 285.
13. V. A. Pollack and I. J. Fidler, Experimental carcinosarcoma Walker 256 solid tumors, J. Natl. Cancer Inst., 69, 137 (1982).
14. K. Shortman and J. Palmer, A direct method for the macrophage activity determination, Cell. Immunol., 2, 399(1971).
15. W. Regelson, Physiological effects of polyanionic macromolecules, Adv. Chemother 3, 303, 1968.
16. I. Neacsu, C. V. Uglea, C. V. Zanoaga, and I. Bara, Bioelectrical effects of benzocaine incorporated into liposomes, Rev. Roumaine Biol. Anim., 37, 27 (1992).
17. C. V. Uglea, Polyanionic polymers with biological activity, Roum. Chem. Q. Rev., 3, 125, 1995.
18. R. Duncan and I. Kopecek, The biocompatibility of macromolecules, 7. Adv. Polym. Sci., 57, 53 (1984).
19. H. Ringsdorf, B. Schlarb, and J. Ventmer, The mechanism of polymer biocompatibility, Angew. Chem. Int. Ed., 27, 113(1988).